News

Orioles sign free agent closer Balfour

Orioles sign free agent closer Balfour

SIGNED: Oakland Athletics' Grant Balfour pitches against the Texas Rangers in the ninth inning of their MLB American League baseball game in Arlington, Texas June 18. Photo: Reuters/Mike Stone

(Reuters) – Australian free-agent closer Grant Balfour has agreed to terms with the Baltimore Orioles on a two-year deal, the Baltimore Sun reported on Tuesday citing multiple industry sources.

Balfour, an All-Star last season who notched 62 saves in 67 opportunities since he became a full-time closer in 2012 for the Oakland Athletics, will be getting a deal worth $15 million with $1 million deferred, pending a physical, the Sun said.

The Sydney native, who will turn 36 later this month, would take over for closer Jim Johnson, who was traded by the Orioles to the Athletics two weeks ago.

Balfour was 1-3 with a 2.59 earned run average and 38 saves in 41 chances for AL West champions Oakland in 2013.

The right-hander, known for his tempestuous antics on the mound which came to be known as the ‘Balfour Rage,’ joined Oakland from Tampa Bay in 2011 after previous major league stops in Minnesota and Milwaukee in his 10-year career.

Recent Headlines

5 hours ago in Viral Videos

Who’s your daddy?

16-overlay-10

When you're a baby and your dad is a twin, life can be confusing.

8 hours ago in Entertainment

Johnny Depp wigs out as Donald Trump in spoof biopic

16-overlay-11

The Hollywood actor dons a Trump-style hairpiece to lampoon the presidential hopeful in the 50-minute comedy for Funny or Die alongside a star-studded cast including Alfred Molina, Henry Winkle

8 hours ago in Entertainment

Another ‘Harry Potter’ book in the works

harrypotter

Fans will have the chance to read another installment in J.K. Rowling's wizard series when her new play is published as a book.

8 hours ago in Viral Videos

WATCH: Oh mother …

23-overlay-3

Is it the worst "Family Feud" answer ever? Judge for yourself.

11 hours ago in Entertainment, National

Shkreli is sued over his $2 million Wu-Tang Clan album

Pharmaceutical chief Martin Shkreli listens on Capitol Hill in Washington, Thursday, Feb. 4, 2016, during the House Committee on Oversight and Reform Committee hearing on his former company's decision to raise the price of a lifesaving medicine. Shkreli refused to testify before U.S. lawmakers who excoriated him over severe hikes for a drug sold by a company that he acquired. (AP Photo/Susan Walsh)

Shkreli has bragged that he had no plans to listen to the album, but bought it to "keep it from the people."